CAR T-Cell Therapy for Leukemia Leads to Remissions in Clinical Trial

Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common adult leukemia had their tumors shrink or disappear following an experimental chimeric antigen receptor (CAR) T-cell immunotherapy. The...
14-Jul-2017 2:05 PM EDT Add to Favorites

Fred Hutch Elects Former Executives From CNN, Gates Foundation and Microsoft as Trustees

Fred Hutchinson Cancer Research Center’s board of trustees yesterday elected three new members, adding expertise in information technology, media and global health as it works to accelerate efforts to develop cures for cancer and other diseases.
29-Jun-2017 2:30 PM EDT Add to Favorites

Fred Hutch Scientists to Develop Bioassay for Ovarian Cancer for New National Cancer Institute Initiative

Dr. Amanda Paulovich of Fred Hutch will lead a multi-institution effort to develop a biological test to predict which treatments will work for patients with ovarian cancer. Photos, video available:...
27-Jun-2017 11:05 AM EDT Add to Favorites

Night Shift Work Associated with Diminished Ability to Repair DNA Damage

A Fred Hutchinson Cancer Research Center study, led by epidemiologist Dr. Parveen Bhatti, found that night shift work is associated with reduced ability to repair DNA lesions. Over time, DNA damage that is not repaired will cause mutations that can...
26-Jun-2017 6:30 PM EDT Add to Favorites

Fred Hutch Study Suggests NSAIDs Improve Survival for Certain Colorectal Cancer Patients

Among long-term colorectal cancer survivors, use of nonsteroidal anti-inflammatory drugs, or NSAIDs, is associated with about a 25 percent reduction in all-cause mortality, according to new research from Fred Hutchinson Cancer Research Center.
13-Jun-2017 7:05 PM EDT Add to Favorites

SWOG Clinical Trials Added More Than 3M Years of Life for Cancer Patients, Fred Hutch Researcher Reports

For an investment of $125 for each year of life gained since the 1950s, the National Cancer Institute-funded SWOG clinical trials program has added 3.34 million years of life for cancer patients in the United States because of successful therapies...
1-Jun-2017 12:45 PM EDT Add to Favorites

Immune Responses From Early Study of Novel Sarcoma Vaccine

The critical component of an experimental vaccine led to an escalating immune response in patients with sarcoma, an indicator of its potential anti-cancer effects. The findings will be presented by Dr. Seth Pollack, a physician-scientist at Fred...
1-Jun-2017 7:05 PM EDT Add to Favorites

Clinical Trial Shows Experimental Drug’s Ability to Knock Down Pancreatic Cancer’s Defense

By adding an experimental drug to a standard chemotherapy regimen, a subset of patients with metastatic pancreatic cancer had a significantly longer period before the cancer progressed as compared with those who received the standard treatment,...
31-May-2017 2:05 PM EDT Add to Favorites